The middlemen of group purchasing organizations and pharmacy benefit managers remain a central part of the drug pricing and shortage debate.
Are GPOs, PBMs part of the drug cost problem or the solution?
The middlemen of group purchasing organizations and pharmacy benefit managers remain a central part of the drug pricing and shortage debate.